Dr. Reddy's Laboratories
RDY
#1702
Rank
HK$97.46 B
Marketcap
HK$116.91
Share price
2.62%
Change (1 day)
11.20%
Change (1 year)

EPS for Dr. Reddy's Laboratories (RDY)

EPS in 2023 (TTM): HK$29.06

According to Dr. Reddy's Laboratories's latest financial reports the company's current EPS (TTM) is HK$2.84. In 2022 the company made an earnings per share (EPS) of HK$21.26 an increase over its 2021 EPS that were of HK$17.99.

EPS history for Dr. Reddy's Laboratories from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$29.0636.71%
2022HK$21.2618.14%
2021HK$17.9934.07%
2020HK$13.4221.36%
2019HK$11.06-7.1%
2018HK$11.9164.13%
2017HK$7.257.5%
2016HK$6.75-61.17%
2015HK$17.385.97%
2014HK$16.40-5.38%
2013HK$17.3346.78%
2012HK$11.81-13.09%
2011HK$13.5841.17%
2010HK$9.62-199.25%
2009-HK$9.70-269.81%
2008HK$5.71-12.82%
2007HK$6.550.54%
2006HK$6.51301.34%
2005HK$1.6272.26%
2004HK$0.94-68.7%
2003HK$3.0125.18%
2002HK$2.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$41.17 1,349.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96 109.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$14.92 425.57%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
HK$22.56 694.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$4.94 74.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel